treosulfan has been researched along with Hepatic Veno Occlusive Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abraham, A; Ahmed, R; Ganapule, A; George, B; Lakshmi, KM; Mathews, V; Sindhuvi, E; Srivastava, A; Viswabandya, A | 1 |
1 other study(ies) available for treosulfan and Hepatic Veno Occlusive Disease
Article | Year |
---|---|
Improved clinical outcomes of high risk β thalassemia major patients undergoing a HLA matched related allogeneic stem cell transplant with a treosulfan based conditioning regimen and peripheral blood stem cell grafts.
Topics: Adolescent; beta-Thalassemia; Bone Marrow Cells; Busulfan; Cause of Death; Child; Child, Preschool; Chimerism; Demography; Female; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Histocompatibility Testing; Humans; Male; Peripheral Blood Stem Cell Transplantation; Risk Factors; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Young Adult | 2013 |